Form 4: T2 Biosystems Director Exercises Restricted Stock Units
SEC Form 4 Filing
John J. Sperzel III, a director and officer of T2 Biosystems, Inc., executed restricted stock units (RSUs) on February 24, 2024, acquiring 67 shares of common stock.
Summary
- On February 24, 2024, John J. Sperzel III, a director and officer of T2 Biosystems, exercised restricted stock units.
- This transaction resulted in the acquisition of 67 shares of T2 Biosystems common stock.
- The RSUs were granted on February 24, 2021, and vest in three equal installments starting February 24, 2022.
- The reporting person now directly owns 400 shares of common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to stock transactions by a company insider, and does not inherently convey positive or negative sentiment.
Positives
- The exercise of RSUs indicates the director's continued investment and belief in the company's future.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it involves a small number of shares.
Key Dates
| Date | Description |
|---|---|
| 02/24/2021 | Reporting person was granted 200 RSU's that vest in three equal installments commencing on February 24, 2022. |
| 02/24/2022 | First vesting date of the RSU's granted on February 24, 2021. |
| 02/24/2024 | Date of transaction: exercise of restricted stock units. |
| 02/27/2024 | Date of signature on the Form 4 filing. |
Keywords
T2 Biosystems, Form 4, RSU, Restricted Stock Units, Director, Officer, Beneficial Ownership, Common Stock, Sperzel
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.